{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:02:04Z","timestamp":1791313324036,"version":"4.3.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Science and Technology Support Program of the People\u2019s Republic of China","award":["2011BAD09B03"],"award-info":[{"award-number":["2011BAD09B03"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165130","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T18:03:45Z","timestamp":1476986625000},"page":"e0165130","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Heterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14"],"prefix":"10.1371","volume":"11","author":[{"given":"Zhu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deju","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/diab.47.2.159","article-title":"Glucagon-like peptides","volume":"47","author":"DJ Drucker","year":"1998","journal-title":"Diabetes"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s001250050613","article-title":"Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7\u201336 amide]) in patients with NIDDM","volume":"39","author":"MA Nauck","year":"1996","journal-title":"Diabetologia"},{"key":"ref3","first-page":"327","article-title":"Gastric emptying, glucose responses and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7\u201336) amide in type 2 (noninsulin-dependent) diabetic patients","volume":"81","author":"B Willms","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00125-004-1327-5","article-title":"Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells","volume":"47","author":"Q Wang","year":"2004","journal-title":"Diabetologia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2009.06.002","article-title":"Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors","volume":"124","author":"EJ Verspohl","year":"2009","journal-title":"Pharmacol Therapeut"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study","volume":"359","author":"M Zander","year":"2002","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/dc13-1473","article-title":"Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes","volume":"37","author":"G Sarkar","year":"2014","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diabetes.47.11.1663","article-title":"Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes","volume":"47","author":"JJ Holst","year":"1998","journal-title":"Diabetes"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mcna.2014.08.013","article-title":"Incretin-based therapies","volume":"99","author":"JJ Neumiller","year":"2015","journal-title":"Med Clin North Am"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00125-005-1707-5","article-title":"Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes","volume":"48","author":"HJ Mest","year":"2005","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"J Eng","year":"1992","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1152\/ajpendo.2001.281.1.E155","article-title":"Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers","volume":"281","author":"CM Edwards","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea treated patients with type 2 diabetes","volume":"27","author":"JB Buse","year":"2004","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes mellitus treated with metformin and a sulfonylurea","volume":"28","author":"DM Kendall","year":"2005","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diabres.2005.11.007","article-title":"GLP-1\/exendin-4 facilitates \u03b2-cell neogenesis in rat and human pancreatic ducts","volume":"73","author":"G Xu","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"issue":"9548","key":"ref16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"DJ Drucker","year":"2006","journal-title":"The Lancet"},{"key":"ref17","unstructured":"Bydureon (exenatide extended-release for injectable suspension) [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2014"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0250-474X.42967","article-title":"Protein and peptide drug delivery: oral approaches","volume":"70","author":"J Shaji","year":"2008","journal-title":"Indian J Pharm Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","article-title":"Oral delivery of therapeutic protein\/peptide for diabetes\u2013Future perspectives","volume":"440","author":"MA Rekha","year":"2013","journal-title":"Int J Pharm"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2174\/1381612822666151216150238","article-title":"Delivery of peptides via the oral route: diabetes treatment by peptide-loaded nanoparticles","volume":"22","author":"O Bouttefeux","year":"2016","journal-title":"Curr Pharm Design"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: revisited approaches","volume":"33","author":"P Fonte","year":"2015","journal-title":"Biotechnol Adv"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s10439-016-1558-x","article-title":"Delivery of exenatide and insulin using mucoadhesive intestinal devices","volume":"44","author":"V Gupta","year":"2016","journal-title":"Ann Biomed Eng"},{"key":"ref23","article-title":"Using peptides to increase transport across the intestinal barrier","author":"M S\u00e1nchez-Navarro","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2015.05.258","article-title":"Oral films as breakthrough tools for oral delivery of proteins\/peptides","volume":"211","author":"PM Castro","year":"2015","journal-title":"J Control Release"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/TDE.15.47","article-title":"Why most oral insulin formulations do not reach clinical trials","volume":"6","author":"M Lopes","year":"2015","journal-title":"Ther Deliv"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s00253-015-6498-0","article-title":"Lactic acid bacteria\u201420 years exploring their potential as live vectors for mucosal vaccination","volume":"99","author":"A Wyszy\u0144ska","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12934-015-0313-6","article-title":"Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes","volume":"14","author":"O Cano-Garrido","year":"2015","journal-title":"Microb Cell Fact"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1007\/s00253-016-7557-x","article-title":"Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option","volume":"100","author":"W Wang","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrgastro.2010.117","article-title":"Probiotics and the gut microbiota in intestinal health and disease","volume":"7","author":"MG Gareau","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0958-6946(99)00132-6","article-title":"Adhesion of probiotic micro-organisms to intestinal mucus","volume":"9","author":"AC Ouwehand","year":"1999","journal-title":"Int Dairy J"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2006.01.013","article-title":"Delivery of TEM beta-lactamase by gene-transformed <italic>Lactococcus lactis<\/italic> subsp. <italic>lactis<\/italic> through cervical cell monolayer","volume":"313","author":"G Kaushal","year":"2006","journal-title":"Int J Pharm"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn&apos;s disease","volume":"4","author":"H Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/bit.23130","article-title":"Nisin-inducible secretion of a biologically active single-chain insulin analog by <italic>Lactococcus lactis<\/italic> NZ9000","volume":"108","author":"DT Ng","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e105701","DOI":"10.1371\/journal.pone.0105701","article-title":"Oral administration of recombinant <italic>Lactococcus lactis<\/italic> expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice","volume":"9","author":"Y Ma","year":"2014","journal-title":"PLOS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s11095-014-1430-3","article-title":"Oral delivery of glucagon like peptide-1 by a recombinant <italic>Lactococcus lactis<\/italic>","volume":"31","author":"P Agarwal","year":"2014","journal-title":"Pharm. Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2337\/db13-1236","article-title":"Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by <italic>Lactococcus lactis<\/italic> reverses diabetes in recent-onset NOD mice","volume":"63","author":"S Robert","year":"2014","journal-title":"Diabetes"},{"key":"ref37","article-title":"An engineered <italic>Bifidobacterium longum<\/italic> secreting a bioactive penetratin-Glucagon-like peptide 1 fusion protein enhances Glucagon-like peptide 1 absorption in the intestine","author":"P Wei","year":"2015","journal-title":"J Microbiol Biotechn"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/db14-0635","article-title":"Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes","volume":"64","author":"FF Duan","year":"2015","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AEM.55.1.224-228.1989","article-title":"Construction of a lactococcal expression vector: expression of hen egg white lysozyme in <italic>Lactococcus lactis<\/italic> subsp. <italic>lactis<\/italic>","volume":"55","author":"M van de Guchte","year":"1989","journal-title":"Appl Environ Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nprot.2006.4","article-title":"Tricine-sds-page","volume":"1","author":"H Sch\u00e4gger","year":"2006","journal-title":"Nat Protoc"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12934-016-0506-7","article-title":"Recombinant <italic>Lactococcus lactis<\/italic> NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT\u201129 cells","volume":"15","author":"B Zhang","year":"2016","journal-title":"Microb Cell Fact"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.49.3.424","article-title":"Isolation of INS-1\u2013derived cell lines with robust ATP-sensitive K+ channel-dependent and-independent glucose-stimulated insulin secretion","volume":"49","author":"HE Hohmeier","year":"2000","journal-title":"Diabetes"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"TD Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"I Hubatsch","year":"2007","journal-title":"Nat Protoc"},{"key":"ref45","first-page":"12","article-title":"A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus","volume":"110","author":"JF Habener","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","article-title":"Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas","volume":"49","author":"DA Stoffers","year":"2000","journal-title":"Diabetes"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/endo.142.5.8128","article-title":"Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate\/protein kinase A-dependent mechanism","volume":"142","author":"X Wang","year":"2001","journal-title":"Endocrinology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2002-29087","article-title":"Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4","volume":"110","author":"A Thum","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"26","key":"ref49","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/sj.onc.1204436","article-title":"Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms","volume":"20","author":"CA Belmokhtar","year":"2001","journal-title":"Oncogene"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/bjo.87.3.346","article-title":"Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line","volume":"87","author":"G Thuret","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2004.08.004","article-title":"Normal flora: living vehicles for non-invasive protein drug delivery","volume":"286","author":"J Shao","year":"2004","journal-title":"Int J of Pharm"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1128\/AEM.67.9.4119-4127.2001","article-title":"Signal peptide and propeptide optimization for heterologous protein secretion in <italic>Lactococcus lactis<\/italic>","volume":"67","author":"Y Le Loir","year":"2001","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0141-0229(00)00297-0","article-title":"Secretion of biologically active murine interleukin-10 by <italic>Lactococcus lactis<\/italic>","volume":"27","author":"L Schotte","year":"2000","journal-title":"Enzyme Microb Technol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00203-010-0606-4","article-title":"Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve","volume":"192","author":"EV Khokhlova","year":"2010","journal-title":"Arch Microbiol"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrmicro1840","article-title":"Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria","volume":"6","author":"JM Wells","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/dc14-0769","article-title":"Insights into the role of the microbiome in obesity and type 2 diabetes","volume":"38","author":"AV Hartstra","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js960085v","article-title":"Physiochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH","volume":"86","author":"WN Charman","year":"1997","journal-title":"J Pharm Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1210\/endo.143.6.8870","article-title":"Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP\/CRE interactions sensitive to serine\/threonine protein kinase inhibitor Ro 31\u20138220","volume":"143","author":"OG Chepurny","year":"2002","journal-title":"Endocrinology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1002099619354","article-title":"The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations","volume":"76","author":"K Hirayama","year":"1999","journal-title":"Antonie van Leeuwenhoek"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anaerobe.2014.04.012","article-title":"Probiotic potential and biotherapeutic effects of newly isolated vaginal <italic>Lactobacillus acidophilus<\/italic> 36YL strain on cancer cells","volume":"28","author":"Y Nami","year":"2014","journal-title":"Anaerobe"},{"key":"ref61","first-page":"323","article-title":"Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture","volume":"47","author":"M Pinto","year":"1983","journal-title":"Biol Cell"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat diet- induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"PD Cani","year":"2007","journal-title":"Diabetologia"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jff.2013.04.014","article-title":"Functional food ingredients for the management of obesity and associated co-morbidities\u2013A review","volume":"5","author":"RK Baboota","year":"2013","journal-title":"J Funct Foods"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00394-013-0568-9","article-title":"Antiobesity effect of <italic>Lactobacillus gasseri<\/italic> SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice","volume":"53","author":"M Miyoshi","year":"2014","journal-title":"Eur J Nutr"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jff.2015.11.030","article-title":"Screening for potential novel probiotic <italic>Lactobacillus<\/italic> strains based on high dipeptidyl peptidase IV and \u03b1-glucosidase inhibitory activity","volume":"20","author":"Z Zeng","year":"2016","journal-title":"J Funct Foods"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:41:35Z","timestamp":1749667295000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165130"}},"subtitle":[],"editor":[{"given":"H\u00e9lder A.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165130","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}